Portfolio company
Amaros AI
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform for clinical trial optimisation and data analysis for ophthalmology clinics, research organisations and therapeutic teams.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Deepeye Medical
This company develops artificial intelligence software that analyses eye scans to provide therapy planning support for ophthalmologists treating retinal diseases.
Optina Diagnostics
This company develops artificial intelligence platforms and hyperspectral retinal imaging cameras to help eye specialists diagnose and manage retinal and neurodegenerative diseases.
Pheiron
This company develops an artificial intelligence platform that analyses clinical and biological data to help pharmaceutical businesses predict drug trial outcomes and identify therapies.
Hope AI
This company develops artificial intelligence software for clinical trial design and drug development for pharmaceutical and biotechnology organisations.
eye2gene
Eye2Gene develops an AI-powered platform that analyses retinal imaging to accelerate genetic diagnosis of inherited diseases for pharmaceutical companies and eye care professionals.
Wivi Vision
This company provides a clinical platform using artificial intelligence and 3D games to assess and treat visual dysfunctions for eye care professionals and patients.
Qureight
This company develops an AI-powered imaging and data curation platform for biopharmaceutical companies to analyse clinical trial endpoints in lung and heart disease.
AI Optics
This company develops handheld retinal imaging devices and artificial intelligence software for healthcare providers to screen and diagnose eye diseases at the point of care.
